VIVUS, Inc. (NASDAQ:VVUS)’s quarterly earnings will be announced on March, 12., according to Zacks. Analysts forecast $-0.53 earnings per share. That’s $0.47 up or 47.00 % from 2018’s earnings of $-1. Last quarter $-0.87 earnings per share was reported. Analysts predicts -39.08 % EPS growth this quarter. Ticker’s shares touched $4.75 during the last trading session after 1.45% change.Currently VIVUS, Inc. is downtrending after 52.05% change in last March 2, 2018. VVUS has also 106,663 shares volume. The stock underperformed the S&P500 by 52.05%.

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union.The firm is valued at $50.52 million. The firm offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol; and STENDRA, an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.Currently it has negative earnings. It is also developing Qsymia, which has completed Phase II studies for the treatment of obstructive sleep apnea and diabetes, as well as for other obesity-related diseases, including nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, hyperlipidemia, and hypertension.

For more VIVUS, Inc. (NASDAQ:VVUS) news announced briefly go to: Globenewswire.com, Nasdaq.com, Nasdaq.com, Investorplace.com or Seekingalpha.com. The titles are as follows: “VIVUS to Present at Biotech Showcase on January 9, 2019 – GlobeNewswire” announced on December 27, 2018, “VIVUS’ (VVUS) Qsymia Falters in a Highly Competitive Market – Nasdaq” on August 22, 2018, “VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster – Nasdaq” with a publish date: January 03, 2019, “3 Biotech Stocks That Pay Solid Dividends – Investorplace.com” and the last “Vivus to reverse split shares 1:10 after the close; post-split trading to commence tomorrow – Seeking Alpha” with publication date: September 10, 2018.